EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2025 Earnings Call Transcript November 5, 2025
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.85127 EPS, expectations were $-0.77.
Operator: Good morning. My name is Antoine, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Third Quarter 2025 Financial Results and Recent Corporate Developments Conference Call. Please be advised that this call is...
